Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Annals of Translational Medicine|September 15, 2015
MET deregulation in breast cancerGabriele Minuti, Lorenza LandiExpert Opinion on Pharmacotherapy|April 22, 2014
Protein kinase inhibitors to treat non-small-cell lung cancerGabriele Minuti, Armida D'Incecco, Lorenza Landi, et al.Current Opinion in Oncology|February 7, 2013
Targeting c-MET in the battle against advanced nonsmall-cell lung cancerLorenza Landi, Gabriele Minuti, Armida D'Incecco, et al.Lung Cancer (Auckland, N.Z.)|February 18, 2017
MET overexpression and gene amplification in NSCLC: a clinical perspectiveLorenza Landi, Gabriele Minuti, Armida D'Incecco, et al.JTO Clinical and Research Reports|December 9, 2025
DESTINY of Immunotherapy in Patients With <i>HER2</i> Mutant Lung Cancer: Case ReportLorenza Landi, Francesca Fusco, Enrico Melis, et al.JTO Clinical and Research Reports|August 3, 2023
Pretreated <i>EGFR</i><sup></sup>/<i>BRAF</i><sup></sup> Lung Adenocarcinoma With Leptomeningeal Disease Achieving Long-Lasting Disease Control on Osimertinib, Dabrafenib, and Trametinib: A Case ReportCorrado Orciuolo, Federico Cappuzzo, Lorenza Landi, et al.Translational Lung Cancer Research|February 3, 2017
Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLCLorenza Landi, Federico CappuzzoExpert Review of Clinical Pharmacology|November 20, 2015
Ceritinib for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancerLorenza Landi, Federico CappuzzoClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
<i>HER2</i> Deregulation in Lung Cancer: Right Time to Adopt an Orphan?Federico Cappuzzo, Lorenza LandiTherapeutic Advances in Respiratory Disease|June 12, 2015
Experience with erlotinib in the treatment of non-small cell lung cancerLorenza Landi, Federico CappuzzoPageof 10